Browsing Category
Medicine
Trio of Studies Suggests Further Need for Women Leaders in Heart Disease Research and Care
In a trio of studies analyzing trends in cardiology research funding, clinical trials and leadership, Johns Hopkins Medicine researchers say some progress has been made in the gender gap that has long favored men, but inequalities persist…
Johns Hopkins Children’s Center Doctors Fix a Hole to Save a Newborn Baby
Sarah Gonzalez was just 13 weeks pregnant in 2018 when she received “terrifying” news during a routine ultrasound. Her unborn baby, whom they planned to name Sullivan, or “Sully,” had a congenital diaphragmatic hernia (CDH). “It was this…
Ministry of Ayush announces flagship event in Gujarat, to be attended by Prime Minister Narendra…
The Global Ayush Investment & Innovation Summit will take place from April 20th – 22nd April in Gandhinagar
New Delhi : Ministry of Ayush today, officially announced their most pertinent event for 2022 – the Global Ayush…
Pfizer: Pfizer and BioNTech Announce Data Demonstrating High Immune Response Following a Booster…
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced positive results from a Phase 2/3 clinical trial evaluating the safety, tolerability and immunogenicity of a 10-µg booster (third) dose of the Pfizer-BioNTech COVID-19!-->…
Pfizer: Myovant Sciences and Pfizer Provide Update on Supplemental New Drug Application for…
Myovant Sciences (NYSE: MYOV) and Pfizer (NYSE: PFE) announced today an update on the Supplemental New Drug Application (sNDA) for MYFEMBREE® (relugolix 40 mg, estradiol 1 mg and norethindrone acetate 0.5 mg) for the management of!-->…
Pfizer: Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates
Pfizer Inc. (NYSE: PFE) and ReViral Ltd. announced today that the companies have entered into a definitive agreement under which Pfizer will acquire ReViral, a privately held, clinical-stage biopharmaceutical company focused on!-->…
Pfizer: Three Year Follow-Up Data from Phase 3 CROWN Trial of Pfizer’s LORBRENA® (lorlatinib)…
Pfizer Inc. (NYSE: PFE) announced updated results from the Phase 3 CROWN trial, which evaluated LORBRENA® (lorlatinib, available in Europe under the brand name LORVIQUA) versus XALKORI® (crizotinib) in people with previously untreated!-->…
Pfizer: Pfizer and BioNTech Receive Expanded U.S. Emergency Use Authorization for an Additional…
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use of their COVID-19 vaccine to include a second booster dose in adults ages 50 years and!-->…
Reduction In Fee Of Medical Colleges/Universities
The Section 10 (Clause (i) of Sub-section (1)) of National Medical Commission Act, 2019 provides for framing of guidelines for determination of fees and all other charges in respect of fifty percent of seats in private medical institutions…
New smartphone-based portable oxygen kit can provide consistent oxygen supply during disasters and…
An easy to handle and transport, multi-modal, smartphone-based, field-portable oxygen kit can now provide consistent and cost-effective oxygen supply to communities during situations like the recent COVID 19 pandemic and other disasters…